SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: drdan who wrote (1018)	6/17/1998 2:12:00 PM
From: Gwolf	Read Replies (1) of 5402

Dr. Dan, the company clearly has the potential to capture 100% of the market considering that the competitors are still using the toxic derivatives of human or cow's blood. I don't think that you were being overly aggressive considering what we know now. There is always a chance that one of the other potential competitors is working secretly on a true 'artifical' substitute or that somehow they can find a way to make the derivatives work out. I have used 10% when in reality I believe it is much higher, but it is better to understate than overstate. Gwolf

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next